stella
beta
The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation — Stella
Recruiting
Back to Poor Graft Function trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Institute of Hematology & Blood Diseases Hospital, China, Tianjin, Tianjin Municipality
View full record on ClinicalTrials.gov